Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

• Linn Hermansson,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliations Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden

  ⨯
• Aylin Yilmaz,

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliations Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden

  ⨯
• Richard W. Price,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliation Department of Neurology, University of California, San Francisco, United States of America

  ⨯
• Staffan Nilsson,

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden

  http://orcid.org/0000-0003-4748-0446

  ⨯
• Scott McCallister,

  Roles Conceptualization, Data curation, Writing – review & editing

  Affiliation Gilead Sciences Inc, Institute of Neuroscience and Physiology, Foster City, California, United States of America

  ⨯
• Tariro Makadzange,

  Roles Data curation, Writing – review & editing

  Affiliation Gilead Sciences Inc, Institute of Neuroscience and Physiology, Foster City, California, United States of America

  ⨯
• Moupali Das,

  Roles Data curation, Writing – review & editing

  Affiliation Gilead Sciences Inc, Institute of Neuroscience and Physiology, Foster City, California, United States of America

  ⨯
• Henrik Zetterberg,

  Roles Formal analysis, Funding acquisition, Methodology, Validation, Writing – review & editing

  Affiliations Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden, Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom, UK Dementia Research Institute, UCL, London, United Kingdom

  ⨯
• Kaj Blennow,

  Roles Formal analysis, Resources, Writing – review & editing

  Affiliations Gilead Sciences Inc, Institute of Neuroscience and Physiology, Foster City, California, United States of America, Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Magnus Gisslen

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing

  * E-mail: magnus.gisslen@gu.se

  Affiliations Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden

  http://orcid.org/0000-0002-2357-1020

  ⨯